Back to Top Skip to main content Skip to sub-navigation

DoD Establishes Collaborative Virus Genetic Sequencing Capability for COVID-19

Image of two scientists in masks looking at a computer monitor Research associate Lindsay Glang and senior bioinformatics analyst Gregory Rice sequencing SARS-CoV-2 genomes on Oxford Nanopore MinION platform at NMRC BDRD. (Photo Courtesy of Naval Medical Research Center, Genomics & Bioinformatics Department.)

Recommended Content:

Armed Forces Health Surveillance Division | Coronavirus | Global Emerging Infections Surveillance

As the pandemic continues to unfold, genetic sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus Disease 2019 (COVID-19), has played a critical role in the public health response, including in the design of diagnostics and vaccines. Within the Department of Defense, SARS-CoV-2 genetic sequence data plays a vital role in force health protection efforts.

To jumpstart the DoD’s SARS-CoV-2 sequencing efforts, Armed Forces Health Surveillance Branch’s Global Emerging Infections Surveillance (GEIS) section used its existing partnerships with Army, Navy, and Air Force public health and medical research laboratories. This connection helped to establish a collaborative approach to the sequencing capabilities. Sequence data from this collaboration will provide critical information about transmission patterns, track diagnostic effectiveness, and guide the development and evaluation of medical countermeasures for the 1.4 million active duty and 331,000 reserve personnel.

“GEIS-funded surveillance provides near-real time understanding of how the SARS-CoV-2 virus is evolving. This information is critical for the development of a vaccine and treatment,” stated Navy Capt. Guillermo Pimentel, GEIS chief. “Previous investments by GEIS in this technology have given our partners the capability to respond and sequence SARS-CoV-2 genomes isolated from DoD Service members around the world.”

In 2017, GEIS established a Next Generation Sequencing and Bioinformatics Consortium to work with GEIS partner DoD laboratories to coordinate and improve pathogen sequencing and analysis efforts around the world. Consortium partners can rapidly detect and characterize known, emerging, and novel infectious disease agents using data from pathogen sequencing. This helps to inform force health protection decision making. The core Consortium partners include: the Naval Medical Research Center (NMRC), U.S. Army Medical Research Institute of Infectious Diseases, Walter Reed Army Institute of Research, U.S. Air Force School of Aerospace Medicine, and the Naval Health Research Center.

“We have used virus sequence data in numerous studies to track virus transmission [such as dengue and influenza],” said Irina Maljkovic Berry, chief of Viral Genetics and Emerging Diseases for the WRAIR Viral Diseases Branch in Silver Spring, Maryland. “We estimate outbreak origins to detect and track vaccine escape and other important mutations throughout the world to aid in vaccine design.”

Consortium partners played a key role in analyzing previous viral outbreaks, such as Ebola in West Africa and Zika in South America, and in seasonal influenza vaccine selection. "Each year we generate thousands of influenza genomes that we use to determine how influenza is evolving or evading our vaccines which directly impact our forces," said Clarise Starr, deputy chief of Pathogen Detection and Therapeutics Portfolio Applied Technology and Genomics Division, U.S. Air Force School of Aerospace Medicine. "These efforts will be the same essential practices that we'll need to deploy in response to SARS-CoV-2."

This open partnership and investment proved extremely helpful in response to the COVID-19 pandemic. DoD laboratories quickly established the ability to isolate the virus, share samples, and compare laboratory methods to improve their sequencing capabilities. “We have been evaluating a few different laboratory sequencing protocols to determine which one works best for samples with certain attributes, in order help increase the efficiency of SARS-CoV-2 sequencing from swabs,” according to Kimberly Bishop-Lilly, head of Genomics & Bioinformatics Department at NMRC in Fort Detrick, Maryland.

The sequence data that's being collected is a valuable source of information to better understand virus transmission patterns among DoD personnel, particularly when combined with other clinical and epidemiological data. These data are also compared to global virus sequence data.

“The goal is to have data and information that could help answer how local outbreaks may have started, how SARS-CoV-2 may have spread in a community or geographic area, and how we can better contain spread or improve interventions,” said Lindsay Morton, GEIS’s senior molecular epidemiologist. Thus far, SARS-CoV-2 sequence data has been gathered from infected personnel at more than 25 locations across the globe.

Additionally, GEIS partners are leveraging this technology to improve understanding of global circulation of SARS-CoV-2 through surveillance programs at DoD overseas labs, such as in Thailand, Peru, Kenya, and Cambodia.

“The OCONUS (Outside Continental United States) labs are starting to stand up SARS-CoV-2 sequencing capabilities and the core labs of the Consortium are providing them reach-back support for sequencing protocols and for bioinformatics analyses,” said Bishop-Lilly. “Consensus viral genomes are being produced at some of the OCONUS labs and we are comparing to viral genomes obtained from samples in other regions such as the U.S., to identify what lineage is predominant in a given geographic region and what key genetic variations may be predominant in a certain area.”

These data will provide a better understanding of transmission in these locations and result in a better understanding of risk to U.S. forces deployed around the world as the COVID-19 pandemic continues. GEIS leaders hope that increased collaboration across the agencies will propel the research and production of an effective vaccine.

“The key to fully utilizing SARS-CoV-2 sequence data is collaboration,” said Morton, “Consortium partners are ready and willing to engage with organizations involved with clinical studies and outbreak investigations across the DoD to better guide the Department’s response to COVID-19 and reduce the impact to readiness and operations around the world.”

You also may be interested in...

Global Influenza Summary: March 5, 2017

Report
3/5/2017

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

March 10 is National Women & Girls HIV/AIDS Awareness Day

Infographic
3/3/2017
This graphic shows the results of routine screening for antibodies to Human Immunodeficiency Virus (HIV) among both female civilian applicants for U.S. military service and female service members of the U.S. Armed Forces, active component - Army during  January 2015 through June 2016 surveillance period. 94,763 females out of 463,132 civilian applicants for U.S. military service were tested for antibodies to HIV. Out of 124 civilian applicants that were HIV positive, 10 were female. Throughout the period, seroprevalences were much higher among males than females.  During 2015 – 2016 seroprevalences dropped to zero among female applicants.  As for U.S. Armed Forces active component, 81,963 female service members out of 548,974 were tested for antibodies to HIV. Out of 120 soldiers that were HIV positive 3 were female. Annual seroprevalences for male active component Army members greatly exceed those of females. During the 2015, on average, one new HIV infection was detected among active duty army soldiers per 5,265 screening tests.  HIV-1 is the cause of Acquired Immune Deficiency Syndrome (AIDS) and has had major impacts on the health of populations and on healthcare systems worldwide. Of 515 active component soldiers diagnosed with HIV infections since 2011, a total of 291 (57%) were still in the military. Get tested and learn more by reading the Medical Surveillance Monthly Report at Health.Mil/MSMR.

Human Immunodeficiency Virus type 1 (HIV-1) is the cause of Acquired Immune Deficiency Syndrome (AIDS) and has had major impacts on the health of populations and on healthcare systems worldwide. This infographic provides information on routine screening for antibodies to HIV among female civilian applicants of the U.S. Military Service and U.S. Armed Forces, January 2011 – June 2016.

Recommended Content:

Armed Forces Health Surveillance Division | HIV/AIDS Prevention and Treatment

Counts, Rates, & Trends of Incedent Diagnoses of Melanoma

Infographic
3/3/2017
Melanoma is a leading cause of cancer death. This graphic shows facts from an analysis for counts, rates, and trends of incident diagnoses of Melanoma among active component military members conducted during a 10-year surveillance period from 2005 through 2014.   Although melanoma is more common among males in the general U.S. population, in this analysis, females had a higher crude rate of malignant melanoma compared to males. From 2005 – 2014, there were 1,571 malignant melanoma cancers diagnosed in the U.S. Armed Forces. Here are other key facts from the analysis: •	Among male service members, malignant melanoma was one of the most frequent cancer diagnoses after testicular cancer. •	Among females, malignant melanoma was the 2nd most frequent cancer diagnoses after breast cancer. •	White, non-Hispanic service members had a much higher crude rate of malignant melanoma relative to their counterparts in other race/ ethnicity groups. •	In general, the strongest demographic correlate of increased risk of cancer diagnosis was older age. To learn more information, visit Health.mil/AFHSB

Melanoma is a leading cause of cancer death. This infographic provides information on an analysis for the counts, rates, and trends of incident diagnoses of melanoma among active component military members. The analysis was conducted during a 10-year surveillance period from 2005 through 2014.

Recommended Content:

Armed Forces Health Surveillance Division

Global Influenza Summary: February 12, 2017

Report
2/12/2017

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Global Influenza Summary: February 5, 2017

Report
2/5/2017

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Global Influenza Summary: January 22, 2017

Report
1/22/2017

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Human Physiologic Responses to Cold Exposure

Infographic
1/9/2017
Human Physiologic responses to cold exposure preserve core body temperature, but those responses may not be sufficient to prevent hypothermia if heat loss is prolonged. This infographic offers helpful information on preserving core body temperature to counter the threat from cold environments. Physiologic responses include: •	Constriction of the peripheral (superficial) vascular system – may result in non-freezing injuries or hasten the onset of actual freezing of tissues (frostbite) •	Minimizing loss of body heat •	Protecting superficial tissues Protection includes:	 •	Nutrition •	Shelter •	Physical Activity •	Protective Clothing Learn more about preserving core body temperature by reading the Medical Surveillance Monthly Report at www.Health.mil/AFHSB

Human Physiologic responses to cold exposure preserve core body temperature, but those responses may not be sufficient to prevent hypothermia if heat loss is prolonged. This infographic offers helpful information on preserving core body temperature to counter the threat from cold environments.

Recommended Content:

Winter Safety | Armed Forces Health Surveillance Division

Global Influenza Summary: January 1, 2017

Report
1/1/2017

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Rift Valley Fever Virus Ecology

Infographic
12/5/2016
This infographic describes Rift Valley Fever (RVF) virus ecology and how RVF infects livestock and humans.   •	First the enzootic cycle begins. It is maintained via transfer from parent mosquito to offspring. This is a local, low-level transfer of disease to livestock and happens during periods of average rainfall. •	Next, high rainfall and flooding enable Aedes mosquito breeding environments to flourish. This is followed by epizootic outbreaks, which cause abortion storms in animals, with > 90% mortality in newborns and 10-20% mortality in adults. Secondary vectors, including other mosquito genera such as Culex, can pass on the virus to humans and animals.  Spillover to humans includes exposure to blood and tissue of infected livestock and occurs during slaughter or birthing activities. Humans can also be infected with RVF via bites of infected mosquitos.

This infographic describes Rift Valley Fever (RVF) virus ecology and how RVF infects livestock and humans.

Recommended Content:

Armed Forces Health Surveillance Division | Mosquito-Borne Illnesses | Bug-Borne Illnesses

Global Influenza Summary: November 20, 2016

Report
11/20/2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Global Influenza Summary: November 6, 2016

Report
11/6/2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Department of Defense continues commitment to Global Health Security Agenda

Article
10/12/2016
Dr. Karen Guice, acting assistant secretary of Defense for Health Affairs, addressed attendees on the second day of the 2016 Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury (TBI) Summit Sept. 14, 2016.

Department of Defense and other senior U.S. government leaders travel to the Netherlands to attend a summit on the Global Health Security Agenda

Recommended Content:

Health Readiness | Global Health Engagement | Building Partner Capacity and Interoperability | Global Health Security Agenda | Armed Forces Health Surveillance Division

Global Influenza Summary: October 2, 2016

Report
10/2/2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Global Influenza Summary: September 3, 2016

Report
9/3/2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Preserving the Health of U.S. Armed Forces with DMSS and DoDSR

Infographic
7/13/2016
The Defense Medical Surveillance System (DMSS) and the DoD Serum Repository (DoDSR) provide unprecedented capabilities for conducting comprehensive population-based surveillance of the U.S. Armed Forces while protecting the privacy and confidentiality of service members. The systems together provide glimpses of the capabilities and potential uses of public health surveillance systems of the future.  The research advantages of the DMSS and DoDSR The DMSS and DoDSR enable researchers to focus time and attention on solving methodological problems, interpreting results, producing summaries and reports.  DMSS includes personnel data, medical data, laboratory data, deployment data, and DoDSR data. Benefactors of the DMSS and DoDSR are epidemiologists, preventive medicine doctors, data analysts, DoD policy makers, Military Commanders and public health officers. Learn how to harness the full value of the DMSS and DoDSR at www.Health.mil/AFHSB

The Defense Medical Surveillance System (DMSS) and the DoD Serum Repository (DoDSR) provide unprecedented capabilities for conducting comprehensive population-based surveillance of the U.S. Armed Forces.

Recommended Content:

Armed Forces Health Surveillance Division | Defense Medical Surveillance System | DoD Serum Repository
<< < ... 41 42 43 44 45  ... > >> 
Showing results 661 - 675 Page 45 of 47

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.